Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:38 PM
Ignite Modification Date:
2025-12-24 @ 12:38 PM
NCT ID:
NCT05271461
Eligibility Criteria:
Inclusion Criteria:
* BMI from 18.5 to 29.9 kg/m2
* Moderate elevated percentage of coagulative factors for COVID-19 Diagnosis:
* Nasopharyngeal swab
* Sepsis induced coagulopathy score\>4
* D\_dimer≥0,5mg/L
* Fibrinogen\>2,5gm/L
* C\_reactive protein≥10mg/L
* Lymphocyte count\<1,500mm3
* Platelet count\<150,000mm3
* Prothrombin time increase\>3sec
* Activated partial thromboplastin time increase\>5sec
* Same level of physical activity
* Patients can swallow tablets
* CT scan screening method for COVID-19 Diagnosis
* Physical examination
Exclusion Criteria:
* hyper tension
* Cognitive impairment e.g (delirium)
* Diabetes mellitus both types dependant or non
* Disabled musculoskeletal Disorders e.g hemi paresis
* Coronary artery diseases and heart failure
* DVT
* Stroke, bone disease, renal failure, pulmonary embolism
* Vitamins deficiency
* 6 months post large surgeries
* Alcohol intake and smokers
* Thyroid diseases
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
45 Years
Study:
NCT05271461
Study Brief:
Protocol Section:
NCT05271461